Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17 JPY | -5.56% | -10.53% | -26.09% |
Business Summary
Number of employees: 60
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Precision Medical Services
99.2
%
| 1,146 | 99.4 % | 1,126 | 99.2 % | -1.81% |
Research and Development of Pharmaceutical Products and Related Business
0.8
%
| 7 | 0.6 % | 9 | 0.8 % | +27.48% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 1,154 | 100.0 % | 1,135 | 100.0 % | -1.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Junichi Shimada
PSD | President | 62 | 30/11/21 |
Zehyon Paku
CTO | Chief Tech/Sci/R&D Officer | 48 | 30/06/17 |
Yuichi Komine
BRD | Director/Board Member | 52 | 31/05/08 |
Yuka Yamane
AUD | Comptroller/Controller/Auditor | 51 | 31/03/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yuichi Komine
BRD | Director/Board Member | 52 | 31/05/08 |
Zehyon Paku
CTO | Chief Tech/Sci/R&D Officer | 48 | 30/06/17 |
Hatsuo Kato
CHM | Chairman | 80 | 31/05/20 |
Yoshio Miki
BRD | Director/Board Member | 67 | 31/05/22 |
Junichi Shimada
PSD | President | 62 | 30/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 217,643,700 | 177,261,700 ( 81.45 %) | 0 | 81.45 % |
Company contact information
OncoTherapy Science, Inc.
Ichigo Kawasaki Building 1-2 Higashidacho
210-0005, Kawasaki
+81 4 4201 6429
http://www.oncotherapy.co.jpSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-26.09% | 23.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4564 Stock
- Company OncoTherapy Science, Inc.